Nizoral Related Published Studies
Well-designed clinical trials related to Nizoral (Ketoconazole)
Multicenter, double-blind, parallel group study investigating the non-inferiority
of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2%
ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]
Multicenter, double-blind, parallel group study investigating the non-inferiority
of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2%
ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]
Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. [2011.07]
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. [2011.04]
Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects. [2011.04]
[Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis]. [2011.02]
Synergistic effects of tetrandrine on the antifungal activity of topical
ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011]
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. [2010.03.01]
Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. [2010.03]
Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6). [2010.01]
Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects. [2009.04]
Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm. [2009.04]
An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2009]
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study. [2009]
Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole. [2008.11.15]
Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study. [2008.11]
Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers. [2008.08]
Effects of ketoconazole and quinidine on pharmacokinetics of pactimibe and its plasma metabolite, R-125528, in humans. [2008.08]
Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial. [2008.05]
Effect of ketoconazole on the pharmacokinetics of maribavir in healthy adults. [2008.05]
Oral Ketoconazole for Prevention of Postoperative Penile Erection: A Placebo Controlled, Randomized, Double-Blind Trial. [2008.03.17]
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. [2007.10]
The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole. [2007.07]
The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during co-administration with ketoconazole. [2007.04.16]
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study. [2007.04.01]
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. [2007.01]
Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. [2007]
Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole. [2007]
Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole. [2006.11]
Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers. [2006.07]
Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial. [2006.07]
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel. [2006.07]
Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. [2006.01]
Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study. [2006]
Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs--a pilot study. [2005.06]
Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers. [2005.06]
Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects. [2005.04]
Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment. [2005.03]
Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences. [2005.03]
Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects. [2005.03]
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases. [2005.03]
Efficacy of a new antidandruff thermophobic foam: a randomized, controlled, investigator-blinded trial vs. ketoconazole 2% scalp fluid. [2005.01]
Influence of ketoconazole on azimilide pharmacokinetics in healthy subjects. [2004.12]
Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects. [2004.10]
Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects. [2004.10]
Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individuals. [2004.08]
Bioequivalence evaluation of two brands of ketoconazole tablets (Onofin-K and Nizoral) in a healthy female Mexican population. [2004.07]
Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study. [2004.06]
A prospective, randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients: ten-year follow-up. [2004.05.15]
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583). [2004.03.15]
Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. [2004.02.01]
A double-blind, randomized, placebo-controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome. [2003.11]
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone. [2003.11]
Limited utility of cyclosporine C2 monitoring in heart transplant recipients receiving ketoconazole. [2003.09]
Gastric function in the elderly: effects on absorption of ketoconazole. [2003.09]
Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study. [2003.06]
Comparative efficacies of oral ketoconazole and terbinafine for reducing Malassezia population sizes on the skin of Basset Hounds. [2003.06]
Interaction between ketoconazole and almotriptan in healthy volunteers. [2003.04]
Treatment of cutaneous leishmaniasis with ketoconazole cream. [2003.01]
Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects. [2003.01]
Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. [2003]
A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. [2002.11]
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. [2002.11]
Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis. [2002.08]
Modulation of irinotecan metabolism by ketoconazole. [2002.07.15]
Fluconazole versus ketoconazole in the treatment of tinea versicolor. [2002.06]
A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis. [2002.06]
Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole. [2002.06]
Ketoconazole increases cocaine and opioid use in methadone maintained patients. [2002.04.01]
Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. [2002.04]
Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin. [2002.02]
Lack of clinically relevant interaction between desloratadine and erythromycin. [2002]
A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. [2002]
Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. [2001.10]
Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis. [2001.09]
Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin. [2001.08]
Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. [2001.06]
The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients. [2001.05]
Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: long-term follow-up and study of metabolic consequences. [2001.03]
Lack of effect of a single dose of ketoconazole on the pharmacokinetics of citalopram. [2001.02]
Systemic ketoconazole for yeast allergic patients with atopic dermatitis. [2001.01]
Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. [2001]
Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus. [2000.12]
Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine. [2000.12]
Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration. [2000.07]
Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. [2000.03]
The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers. [2000]
Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men. [1999.12]
The effects of ketoconazole on the pharmacokinetics of cyclosporine A in cats. [1999.11]
Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans. [1999.10]
Limited efficacy of ketoconazole in treatment-refractory major depression. [1999.10]
Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovary syndrome. [1999.07]
Antiglucocorticoid treatment of depression: double-blind ketoconazole. [1999.04.15]
A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. [1999.04]
The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine. [1999.03]
Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine. [1999.01]
Topical treatment of dermatophytosis and cutaneous candidosis with flutrimazole 1% cream: double-blind, randomized comparative trial with ketoconazole 2% cream. [1999]
Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole. [1998.12]
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole. [1998.12]
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. [1998.12]
The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin. [1998.11]
|